Avantor names Ludovic Brellier to lead bioscience unit and transformation

Avantor Inc. (NYSE: AVTR) announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products and Chief Transformation Officer on May 1, 2026.

Brellier will oversee the growth of the BMP business and operational performance improvements while leading the Revival Management Office to drive transformation initiatives across the company.

The executive joins Avantor from Danaher, where he served as President of Cytiva's Hardware Solutions business, leading five business units responsible for innovation through manufacturing and commercialization of services for the biopharma industry. At Cytiva, he previously held roles as President of Integrated Solutions & Services and VP Business Operations. He also led the establishment of Cytiva as a standalone operating company within Danaher and oversaw the integration of Pall Life Sciences and Cytiva.

"Ludovic is a skilled operator who has a successful track record of growing bioprocessing businesses both organically and inorganically, and our BMP segment is a strong platform that has a lot of potential for growth under his leadership," said Emmanuel Ligner, Avantor's President and CEO.

Brellier stated that he looks forward to leveraging his manufacturing and commercialization experience to enhance operations and drive growth in the business.

Benoit Gourdier, current Executive Vice President of Avantor's BMP Segment, will remain with the company until the end of 2026 to ensure a smooth transition.

Avantor provides mission-critical products and services to customers in the life sciences and advanced technology industries, serving more than 300,000 customer locations in 180 countries.

You May Also Be Interested In

• Increasing unusual option volume: AVTR AMPG OPTU LASE PRGO NASA NNDM CPSH
• Guaranteed Rate Affinity names Charity Moreland VP of national builder unit
• Build-A-Bear names Chris Hurt as new CEO in leadership transition